Patent · US Expired

Intranasal administration of polypeptides in powdered form

US6815424B2 · kind B2 · utility

22Cited by

12References

10Claims

0Family size

Assignee

PFIZER INC. · US

Inventors

Brian H. Vickery · Cupertino, US
Eric Benjamin · Pomona, US
Cherng-Chyi Fu · Saratoga, US
Lynda M. Sanders · Palo Alto, US

Key dates

Filing date	Dec 23, 2002
Grant date	Nov 9, 2004
Priority date	—
Expiry date	Dec 23, 2022

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/36
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions of biologically active polypeptides in powder form suitable for nasal administration, comprising a therapeutically effective amount of a biologically active polypeptide and a water-soluble polysaccharide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.